APA (7th ed.) Citation

Rafeek, R. A. M., Ketheesan, N., Good, M. F., Pandey, M., & Lepletier, A. Low-dose interleukin 2 therapy halts the progression of post-streptococcal autoimmune complications in a rat model of rheumatic heart disease. American Society for Microbiology.

Chicago Style (17th ed.) Citation

Rafeek, Rukshan Ahamed Mohamed, Natkunam Ketheesan, Michael F. Good, Manisha Pandey, and Ailin Lepletier. Low-dose Interleukin 2 Therapy Halts the Progression of Post-streptococcal Autoimmune Complications in a Rat Model of Rheumatic Heart Disease. American Society for Microbiology.

MLA (9th ed.) Citation

Rafeek, Rukshan Ahamed Mohamed, et al. Low-dose Interleukin 2 Therapy Halts the Progression of Post-streptococcal Autoimmune Complications in a Rat Model of Rheumatic Heart Disease. American Society for Microbiology.